FDA Drafts Rules for Proving Generic Estradiol Works Down There
Published Date: 12/8/2025
Notice
Summary
The FDA just dropped new draft guidance for companies making estradiol vaginal inserts and tablets. This guidance helps drug makers design studies to prove their products work the same as already approved ones, speeding up approval. Industry folks should send their feedback by February 6, 2026, so the FDA can finalize the rules—saving time and money in the long run!
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
Draft BE Guidance for Estradiol Generics
If you make generic estradiol vaginal products, the FDA released draft product-specific guidances that give recommendations on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for estradiol vaginal inserts and estradiol vaginal tablets. The guidance names IMVEXXY (NDA 208564, approved May 2018) as the reference listed drug (RLD) for vaginal inserts and VAGIFEM (NDA 020908, approved March 1999) as the RLD for vaginal tablets.
Stakeholder Comment Deadline
Stakeholders, including drug makers, must submit electronic or written comments on the draft guidances by February 6, 2026 for FDA to consider them before it begins work on final versions. Comments go to docket FDA-2007-D-0369 via Regulations.gov or written/paper submission to FDA's Dockets Management Staff.
Paperwork Collections and OMB Approvals
The draft guidances contain no new collections of information but refer to previously approved FDA collections under OMB control numbers 0910-0014 (21 CFR part 312 for investigational new drugs) and 0910-0001 (21 CFR part 314 and part 320 for applications and bioequivalence requirements).
FDA Will Consider Cost Comments
As FDA develops any final guidance, it will consider comments on costs or cost savings the guidance may generate, including comments relevant to Executive Order 14192. Stakeholders may submit such comments by February 6, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11966 — Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help businesses fill out Forms FDA 3542a and FDA 3542 without confusion. If you submit these forms, this guide answers your top questions and makes the process smoother. You’ve got until August 14, 2026, to send in your feedback before the FDA finalizes the guide—no extra costs, just clearer steps!
2026-11998 — Amendment and Revocation of Organizational Information Regulations
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
Previous / Next Documents
Previous: 2025-22247 — Final Flood Hazard Determinations
FEMA has finalized updates to flood risk maps for several communities, changing flood zones and water levels that affect flood insurance rules. Homeowners and businesses in these areas should check the new maps by September 3, 2025, because these changes could impact insurance costs and building rules. These updates help keep communities safer and insurance programs fair.
Next: 2025-22251 — Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company
Some folks want to buy shares in banks or bank companies, and the Federal Reserve is checking their applications to make sure everything’s on the up and up. If you want to share your thoughts, you’ve got until December 23, 2025, to speak up. This process helps keep banks safe and sound while letting new owners step in smoothly.